Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry

European Journal of Endocrinology

Volumn 171, Issue 3, 2014, Pages 389-397

  Wagner, I V ^a   Paetzold, C ^b   Gausche, R ^b   Vogel, M ^b   Koerner, A ^b   Thiery, J ^b   Arsene, C G ^c   Henrion, A ^c   Guettler, B ^c   Keller, E ^a   Kiess, W ^a   Pfaeffle, R ^a   Kratzsch, J ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; ENDOCRINE FUNCTION TEST; EVIDENCE BASED PRACTICE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE STIMULATION TEST; HUMAN; IMMUNOASSAY; ISOTOPE DILUTION ASSAY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BIOSYNTHESIS; BLOOD; BODY HEIGHT; FACTUAL DATABASE; FEMALE; GROWTH DISORDER; MALE; PHYSIOLOGY; PRESCHOOL CHILD; STANDARD;

BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; MALE; MASS SPECTROMETRY; RETROSPECTIVE STUDIES;

EID: 84907208061     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0165     Document Type: Article

References (33)

1. Wales JK, Wit JM & Rogol AD. Pediatric Endocrinology and Growth. London: Saunders, 2003.
2. Eskes SA, Tomasoa NB, Endert E, Geskus RB, Fliers E & Wiersinga WM. Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency. Netherlands Journal of Medicine 2009 67 127-133.
3. Frasier DS. A preview of growth hormone stimulation tests in children. Pediatrics 1974 53 929-937.
4. Kaplan SL, Abrams CAL, Bell JJ, Conte FA & Grumbach MM. Growth and growth hormone. Changes in serum level of growth hormone following hypoglycemia in 134 children with growth retardation. Pediatric Research 1968 2 43-63. (doi:10.1203/00006450-196801000- 00005)
5. Youlton R, Kaplan SL & Grumbach MM. Growth and growth hormone. IV. Limitations of the growth hormone response to insulin and arginine and of the immunoreactive insulin response to arginine in the assessment of growth hormone deficiency in children. Pediatrics 1969 43 989-1004.
6. Brook CGD & Hindmarsch PC. Tests for growth hormone secretion. Archives of Disease in Childhood 1991 66 85-87. (doi:10.1136/adc. 66.1.85)
7. Stimmler L & Brown GA. Growth hormone secretion provoked by insulin-induced hypoglycaemia in children of short stature. Archives of Disease in Childhood 1969 42 232-238. (doi:10.1136/adc.42.223.232)
8. Carel JC, Tresca J-P, Letrait M, Chaussain J-L, Lebouc Y, Job J-C & Coste J. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. Journal of Clinical Endocrinology and Metabolism 1997 82 2117-2121. (doi:10.1210/jcem.82.7.4106)
9. Roth J, Glick SM, Yalow RS & Berson SA. Secretion of human growth hormone: physiologic and experimental modification.Metabolism 1963 12 577-579.
10. Binder G, Huller E, Blumenstock G & Schweizer R. Auxology-based cut-off values for biochemical testing of GH-secretion in childhood. Growth Hormone & IGF Research 2011 2 212-218. (doi:10.1016/j.ghir. 2011.05.007)
11. Binder G. Growth hormone deficiency: new approaches to the diagnosis. Pediatric Endocrinology Reviews 2011 1 535-537.
12. Werther GA. Growth hormone measurements versus auxology in treatment decisions: the Australian experience. Journal of Pediatrics 1996 128 47-51. (doi:10.1016/S0022-3476(96)70011-2)
13. Binder G. Guideline of the German Society of Endocrinology/Study Group Pediatric Endocrinology/Diabetology. Diagnostics of growth hormone deficiency in childhood and adolescence. Extensive version. See http://www.uni-duesseldorf.de/AWMF/ii.
14. GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society. Journal of Clinical Endocrinology and Metabolism 2000 85 3990-3993.
15. Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clinical Chemistry 2011 57 555-559. (doi:10.1373/clinchem.2010. 150631)
16. Strasburger CJ & Bidlingmaier M. How robust are laboratory measures of growth hormone status? Hormone Research 2005 64 1-5. (doi:10.1159/000087745)
17. Bidlingmaier M & Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Hormone & IGF Research 2010 20 19-25. (doi:10.1016/j.ghir.2009.09.005)
18. Manolopoulou J, Alami Y, Petersenn S, Schopohl J, WuZ, Strasburger CJ & Bidlingmaier M. Automated 22-kD growth hormone-specific assay without interference from Pegvisomant. Clinical Chemistry 2012 58 144-156. (doi:10.1373/clinchem.2012.188128)
19. Müller A, Scholz M, Blankenstein O, Binder G, Pfäffle R, Körner A, Kiess W, Heider A, Bidlingmaier M, Thiery J et al. Harmonization of growth hormone measurements with different immunoassays by data adjustment. Clinical Chemistry and Laboratory Medicine 2011 49 1135-1142.
20. Arsene CG, Henrion A, Diekmann N, Manolopoulou J & Bidlingmaier M. Quantification of growth hormone in serum by isotope dilution mass spectrometry. Analytical Biochemistry 2010 401 228-235. (doi:10.1016/j.ab.2010.03.005)
21. Arsene CG, Schulze D, Kratzsch J & Henrion A. High sensitivity mass spectrometric quantification of serum growth hormone by amphiphilic peptide conjugation. Journal of Mass Spectrometry 2012 47 1554-1560. (doi:10.1002/jms.3094)
22. Burkitt WI, Pritchard C, Arsene C, Henrion A, Bunk D & O'Connor G. Toward Système International d'Unité-traceable protein quantification: from amino acids to proteins. Analytical Biochemistry 2008 376 242-251. (doi:10.1016/j.ab.2008.02.010)
23. Hoepffner W, Pfaeffle W, Gausche R, Meigen C & Keller E. Early detection growth disorders with the CrescNet system at the Leipzig treatment center. Deutsches Ärzteblatt 2011 8 123-128.
24. CLSI. Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures; Approved Guidelines-Third Edition. CLSI document EP10-AS-AMP. Wayne PA: Clinical and Laboratory Standards Institute, 2014.
25. MedCalc 12.5.0.0 - 64-bit, ©1993-2013 MedCalc-Software bvba; MedCalc software, Acacialaan 22, B-8400 Ostend, Belgium. http://www.medcalc.org.
26. Bauman JE. Stability of radioimmunoassayable steroid and protein hormones after repeated freeze-thaw cycles. Clinical Chemistry 1982 28 2336-2337.
27. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. European Journal of Endocrinology 2005 153 257-264. (doi:10.1530/eje.1.01967)
28. Klose M, Stochholm K, Janukonyte J, Lehman Christensen L, Frystyk J, Andersen M, Laurberg P, Christiansen JS & Feldt-Rasmussen U. Prevalence of posttraumatic growth hormone deficiency is highly dependent on the dianostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism. Journal of Clinical Endocrinology and Metabolism 2014 99 101-110. (doi:10.1210/jc.2013-2397)
29. Ranke MB. Growth hormone deficiency: diagnostic principles and practice. In Diagnostics of Endocrine Function in Children and Adolescents, 4th edn, pp 115-124. Eds MB Ranke & PE Mullis. Basel: Karger, 2011.
30. Hilczer M, Smyczynska J, Stawerska R & Lewinski A. Stability of IGF-I concentration despite divergent results of repeated GH stimulating tests indicates poor reproducibility of test results. Endocrine Regulations 2006 40 37-45.
31. Fisker S, Jørgensen JO & Christiansen JS. Variability in growth hormone stimulation tests. Growth Hormone & IGF Research 1998 8 31-35. (doi:10.1016/S1096-6374(98)80006-3)
32. Boulo S, Hanisch K, Bidlingmaier M, Arsene CG, Panteghini M, Auclair G, Sturgeon C, Schimmel H & Zegers I. Gaps in the traceability chain of human growth hormone measurements. Clinical Chemistry 2013 59 1074-1082. (doi:10.1373/clinchem.2012.199489)
33. Arsene CG, Ohlendorf R, Burkitt W, Pritchard C, Henrion A, O'Connor G, Bunk DM & Güttler B. Protein quantification by isotope dilution mass spectrometry of proteolytic fragments: cleavage rate and accuracy. Analytical Chemistry 2008 80 4154-4160. (doi:10.1021/ac7024738)